T-cell activation in HLA-B8,DR3-positive individuals early antigen expression defect in vitro
- 30 April 1995
- journal article
- Published by Elsevier in Human Immunology
- Vol. 42 (4) , 289-294
- https://doi.org/10.1016/0198-8859(94)00103-w
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- In Vitro Cytokine Production by HLA-B8, DR3 Positive SubjectsAutoimmunity, 1994
- Discordance for autoimmunity in monozygotic twins. are “identical” twins really identical?Arthritis & Rheumatism, 1993
- Ancestral haplotypes: conserved population MHC haplotypesHuman Immunology, 1992
- Multiparametric Flow Cytometric Analysis of the Kinetics of Surface Molecule Expression after Polyclonal Activation of Human Peripheral Blood T LymphocytesScandinavian Journal of Immunology, 1992
- Hla-Bb, Dr3 T Cell Impairhent is Completely Restored by in Vitho Treatment with Interleukin-2Immunopharmacology and Immunotoxicology, 1991
- Mechanism of a lymphocyte abnormality associated with HLA-B8/DR3: role of interleukin-1Clinical and Experimental Immunology, 1990
- HLA‐B8,DR3 PHENOTYPE AND LYMPHOCYTE RESPONSES TO PHYTOHAEMAGGLUTININInternational Journal of Immunogenetics, 1990
- Soluble Interleukin-2 Receptor Secretion Defectin Vitroin HLA-B8, DR3 Positive SubjectsAutoimmunity, 1990
- Special characteristics of cellular immune function in normal individuals of the HLA-DR3 typeClinical Immunology and Immunopathology, 1982
- Defective Fc-Receptor Functions Associated with the HLA-B8/DRw3 HaplotypeNew England Journal of Medicine, 1981